재고 위치

New Jersey, USA
Czech Republic, EU
Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

15307-86-5Aceclofenac EP Impurity A

● 재고 있음

카탈로그 번호:	VL284007
CAS 번호:	15307-86-5
분자식:	C14H11Cl2NO2
분자량:	296.15 g/mol

견적 요청

RFQ 목록에 추가

에 대한 추가 정보 CAS 15307-86-5

모약물

Aceclofenac

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Additional Characterization Data

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

IUPAC명

2-(2-((2,6-dichlorophenyl)amino)phenyl)acetic acid

Pharmacopeial Synonyms

Diclofenac

동의어

Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-; Diclofenac acid; [ 2-(2,6-Dichloroanilino)phenyl]acetic acid

SMILES

C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl

InChI

InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)

Shipping Condition

Ambient Temperature

설명

Aceclofenac EP Impurity A, also referred to in pharmacopoeias as Diclofenac, is a meticulously characterized reference standard. It adheres to stringent regulatory guidelines, including those established by USP, EMA, JP, and BP. This product plays a vital role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Aceclofenac. Furthermore, it is accompanied by a comprehensive Structure Elucidation Report (SER), ensuring its accuracy and reliability across various analytical applications. Also known as Diclofenac Sodium, Dichlofenac, Diclofenac Acid, it is a non-steroidal anti-inflammatory drug (NSAID) supported for use in painful and inflammatory rheumatic and some non-rheumatic conditions. It suppresses acute and chronic inflammation, pain, and hyperthermia in various animal models.

References

Todd, Peter A., and Eugene M. Sorkin. “Diclofenac Sodium.” Drugs, vol. 35, no. 3, Mar. 1988, pp. 244–85, https://doi.org/10.2165/00003495-198835030-00004. ?